CRISPR Therapeutics AG (CRSP) is a gene editing company focused on developing transformative gene-based medicines for serious diseases. That sounds amazing but it is also a stock with some bullish charts. Let's check them out.
More from Stocks
Avoid the beauty contest of price momentum that has arguably led to relatively large extremes of overvaluation today.
The Fed backs off on claims that inflation is transitory and sets the stage for future rate hikes.